137 related articles for article (PubMed ID: 6745315)
1. Muscarinic cholinoceptors in the rabbit's myometrium: a study of the relationship between binding and response.
Crankshaw DJ
Eur J Pharmacol; 1984 May; 101(1-2):1-10. PubMed ID: 6745315
[TBL] [Abstract][Full Text] [Related]
2. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the affinity constant of some muscarinic receptor antagonists with their displacement of [3H]quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig.
Choo LK; Mitchelson FJ
J Pharm Pharmacol; 1985 Sep; 37(9):656-8. PubMed ID: 2867189
[TBL] [Abstract][Full Text] [Related]
4. Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
Scott T; McMahon KK
J Pharmacol Exp Ther; 1988 Oct; 247(1):136-42. PubMed ID: 3171971
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
Aronstam RS; Ryan US; Catravas JD
Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
[TBL] [Abstract][Full Text] [Related]
7. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic cholinergic receptors in developing rat lung.
Whitsett JA; Hollinger B
Pediatr Res; 1984 Nov; 18(11):1136-40. PubMed ID: 6514439
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
Hoover RK; Toews ML
J Pharmacol Exp Ther; 1989 Oct; 251(1):63-70. PubMed ID: 2795471
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
11. Influence of oestrogens on muscarinic receptor density and contractile response in the guinea-pig uterus.
Matucci R; Bianchi B; Mantelli L; Ghelardini C; Vannelli GB; Maggi M
J Reprod Fertil; 1996 Jul; 107(2):153-60. PubMed ID: 8882279
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
Nilvebrant L; Sparf B
Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
14. Lack of [3H]quinuclidinyl benzylate binding to biologically relevant binding sites on mononuclear cells.
Adams EM; Lubrano TM; Gordon J; Fields JZ
Brain Behav Immun; 1992 Sep; 6(3):307-13. PubMed ID: 1392105
[TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of the muscarinic receptor subtype in rabbit pancreas.
van Zwam AJ; Willems PH; Rodrigues de Miranda JF; de Pont JJ; van Ginneken CA
J Recept Res; 1990; 10(1-2):119-35. PubMed ID: 2262932
[TBL] [Abstract][Full Text] [Related]
16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
17. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
18. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
19. Characterization of muscarinic receptors in rat kidney.
Blankesteijn WM; Siero HL; Rodrigues de Miranda JF; van Megen YJ; Russel FG
Eur J Pharmacol; 1993 Jan; 244(1):21-7. PubMed ID: 8420789
[TBL] [Abstract][Full Text] [Related]
20. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
